› Forums › General Melanoma Community › Merck EAP
- This topic has 12 replies, 3 voices, and was last updated 11 years ago by
cbs805.
- Post
-
- April 20, 2014 at 8:55 pm
Hello everyone,
I am a newbie here and trying to catch up. Ihave read about Merck pd1.
I know that there are a few locations sites in California that people are saying are open.
I would sincerely appreciate it if anyone can CONFIRM that a Merck EAP is in fact open and are now going thru the qualification process or has a date to start infusions.
We live in Northern CA, My husband is stage 4. He has failed IPI & Braf. We need to get into the Merck EAP ASAP.
Thank in advance for your reply. God Bless you all!
MaryBeth
- Replies
-
-
- April 20, 2014 at 9:41 pm
Yes my nurse confirmed the one in beverly hills CA on March 31st and I had failed zel but now I also have to fail the taf/mek combo so dunno if other docs are doing that too but I was doing great on it until a few days ago. Sorry sidetracked. I'm not sure if that one is different that the angeles clinic but she did not confirm it.
Anyway here is a link for catherine pool on the international site with other states plus you can contact her as well.
-
- April 20, 2014 at 9:41 pm
Yes my nurse confirmed the one in beverly hills CA on March 31st and I had failed zel but now I also have to fail the taf/mek combo so dunno if other docs are doing that too but I was doing great on it until a few days ago. Sorry sidetracked. I'm not sure if that one is different that the angeles clinic but she did not confirm it.
Anyway here is a link for catherine pool on the international site with other states plus you can contact her as well.
-
- April 20, 2014 at 9:41 pm
Yes my nurse confirmed the one in beverly hills CA on March 31st and I had failed zel but now I also have to fail the taf/mek combo so dunno if other docs are doing that too but I was doing great on it until a few days ago. Sorry sidetracked. I'm not sure if that one is different that the angeles clinic but she did not confirm it.
Anyway here is a link for catherine pool on the international site with other states plus you can contact her as well.
-
- April 20, 2014 at 11:15 pm
Mayo Clinic Cancer Center announced that it is participating in an expanded access program for the experimental cancer drug MK-3475 at its three sites in Arizona, Florida and Minnesota. MK-3475 is a therapy for the treatment of metastatic melanoma. This program will provide expanded access to the drug prior to its approval by the Food and Drug Administration (FDA).
The expanded access program for MK-3475 is available at Mayo Clinic Cancer Center sites in Arizona, Florida and Minnesota. For more information, call 507-538-7623.
-
- April 20, 2014 at 11:15 pm
Mayo Clinic Cancer Center announced that it is participating in an expanded access program for the experimental cancer drug MK-3475 at its three sites in Arizona, Florida and Minnesota. MK-3475 is a therapy for the treatment of metastatic melanoma. This program will provide expanded access to the drug prior to its approval by the Food and Drug Administration (FDA).
The expanded access program for MK-3475 is available at Mayo Clinic Cancer Center sites in Arizona, Florida and Minnesota. For more information, call 507-538-7623.
-
- April 20, 2014 at 11:16 pm
Here is the url link for Mayo Clinic story:
-
- April 20, 2014 at 11:16 pm
Here is the url link for Mayo Clinic story:
-
- April 20, 2014 at 11:16 pm
Here is the url link for Mayo Clinic story:
-
- April 20, 2014 at 11:15 pm
Mayo Clinic Cancer Center announced that it is participating in an expanded access program for the experimental cancer drug MK-3475 at its three sites in Arizona, Florida and Minnesota. MK-3475 is a therapy for the treatment of metastatic melanoma. This program will provide expanded access to the drug prior to its approval by the Food and Drug Administration (FDA).
The expanded access program for MK-3475 is available at Mayo Clinic Cancer Center sites in Arizona, Florida and Minnesota. For more information, call 507-538-7623.
-
- You must be logged in to reply to this topic.